CNV 1014802 hydrochloride - GSK 1014802 HCl | GSK2 HCl | Raxatrigine HCl

Based on 56 reference(s) in Google Scholar 9 10 56

Axon 2548

CAS [934240-31-0]

MF C18H19FN2O2.HCl
MW 350.82

  • Purity: 99%
  • Soluble in water and DMSO

CNV 1014802 hydrochloride

Description

Sodium channel blocker with potent anticonvulsant activity; potential for novel treatment for Schizophrenia. CNV 1014802 (GSK2) was tested in clinical trials for treatment of trigeminal neuralgia, and shows selectivity for the Nav1.7 subtype over the other subtypes tested (Nav1.1, Nav1.2, Nav1.3, Nav1.5, Nav1.6 and TTX-R), for both the resting and depolarized states.

The parent molecule of CNV 1014802 (Axon 1899) is available as well.

KEYWORDS: CNV1014802 hydrochloride | supplier | Na+ channel blocker | GSK 1014802 HCl | GSK2 HCl | Raxatrigine HCl |CNV1014802A | GSK1014802A | CAS [934240-31-0] | [934240-30-9] | Sodium | Nav1.7 | Nav1.2 | Nav1.6 | Nav1.3 | Blocker | Ion Channel | anticonvulsant | Schizophrenia | trigeminal neuralgia | neuropathic | pain

Order
Size Unit Price Stock
5 mg €125.00 In Stock
25 mg €475.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...